Look for:

Our offer for

KONINKLIJKE PHILIPS NV


ISIN:
NL0000009538
WKN:
0953

2023/06/09 22:26:25
Price
18.278 EUR
Difference 0.77% (0.14)

General attributes

ISINNL0000009538
SymbolPHIA
ExchangeTradegate
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)16,798 EUR
BenchmarkAMSTERDAM EXCHANGES INDEX

Market data

Bid (Bid size)18.266 EUR (290)
Ask (Ask size)18.29 EUR (290)
Open18.158 EUR
High18.384 EUR
Low18.08 EUR
Close (prev. day)18.138 EUR
VWAP18.30499 EUR
Volume (pcs)12,852
Trading volume235,255.72
Number of trades46
Last size-

Futures and Options

Related Futures53
Related Options-

PDF Downloads

Company report: KONINKLIJKE PHILIPS NVPDF Download

Scale: ABS REL         Instrument
Interactive chart

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research

Date Headline Download
2023/06/06 en Global Equity Ratings PDF Download
2023/06/01 en Global Equity Ratings PDF Download
2023/05/24 en Global Equity Ratings PDF Download
2023/05/03 en Global Equity Ratings PDF Download
2023/04/25 en Global Equity Ratings PDF Download


2023/06/09 22:26:25
Price
18.278 EUR
Difference 0.77% (0.14)

General attributes

ISINNL0000009538
SymbolPHIA
ExchangeTradegate
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)16,798 EUR
BenchmarkAMSTERDAM EXCHANGES INDEX

Market data

Bid (Bid size)18.266 EUR (290)
Ask (Ask size)18.29 EUR (290)
Open18.158 EUR
High18.384 EUR
Low18.08 EUR
Close (prev. day)18.138 EUR
VWAP18.30499 EUR
Volume (pcs)12,852
Trading volume235,255.72
Number of trades46
Last size-

Performance and Risk

6m1Y3Y
Perf (%)+41.48%-16.34%-53.08%
Perf (abs.)+5.36-3.57-20.69
Beta1.211.211.00
Volatility37.4440.9533.96
Scale: ABS REL         Instrument
Interactive chart

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)18.113 EUR (16,419)
Ø price 30 days | Ø volume 30 days (pcs.)18.377 EUR (17,036)
Ø price 100 days | Ø volume 100 days (pcs.)16.318 EUR (31,775)
Ø price 250 days | Ø volume 250 days (pcs.)16.002 EUR (33,246)
YTD High | date20.225 EUR (2023/05/16)
YTD Low | date13.488 EUR (2023/01/02)
52 Weeks High | date21.907 EUR (2022/06/10)
52 Weeks Low | date11.602 EUR (2022/11/03)

All listings for KONINKLIJKE PHILIPS NV

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2023/06/0917:3518.114 EUR0.1736
Vienna Stock Exchange2023/06/0909:0518.30 EUR0.001
Tradegate2023/06/0922:2618.278 EUR0.2446
Stuttgart2023/06/0916:1918.228 EUR0.0110
SIX Swiss Exchange2022/06/0215:2047.0683 CHF0.001
Munich2023/06/0908:0018.126 EUR0.001
London Stock Exchange European Trade Reporting2023/06/0917:3018.301 EUR0.002
Hanover2023/06/0908:1518.094 EUR0.001
Hamburg2023/06/0916:0118.252 EUR0.012
Frankfurt2023/06/0919:0918.234 EUR0.1012
FINRA other OTC Issues2023/06/0721:3518.992 USD0.013
Euronext Milan MTF Trading After Hours2023/02/1320:1215.704 EUR0.001
Euronext Milan MTF Global Equity Market2023/06/0917:4418.292 EUR0.036
Euronext Amsterdam2023/06/0917:3718.242 EUR39.785,091
Duesseldorf2023/06/0921:0018.238 EUR0.0010
Berlin2023/06/0921:5218.274 EUR0.0017
BX Swiss2023/06/0818:0017.369 CHF0.011

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=2324&ID_TYPE_IMAGE_LOGO=2

Contact Details

KONINKLIJKE PHILIPS NV
- -
Philips Center, Amstelplein 2 - 1096 BC Amsterdam
Telefon: +31-20-597-77-77
Fax: +
E-mail: -

PDF Downloads

Company report: KONINKLIJKE PHILIPS NVPDF Download

Company Profile

Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment businesses; Connected Care businesses; Personal Health businesses; and Other. The Diagnosis and Treatment businesses segment consists systems, smart devices, software and services, powered by AI-enabled informatics-that support precision diagnoses and minimally invasive procedures in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care businesses segment consists Hospital Patient Monitoring, Emergency Care, Sleep & Respiratory Care and Connected Care Informatics. The Personal Health businesses segment consists of Oral Healthcare, Personal Care,Mother and Child Care. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Members of Management Board

Frans von HoutenChairman of Managing Board
Abhijit BhattacharyaMember of Executive Committee
Andy HoMember of Executive Committee
Bert van MeursMember of Executive Committee
Daniela SeabrookMember of Executive Committee
Deeptha KhannaMember of Executive Committee
Edwin PaalvastMember of Executive Committee
Kees WesdorpMember of Executive Committee
Marnix van GinnekenMember of Executive Committee
Roy JakobsMember of Executive Committee
Shez PartoviMember of Executive Committee
Sophie BechuMember of Executive Committee
Vitor RochaMember of Executive Committee

Board of directors

Feike SijbesmaChairman of Supervisory Board
A. HarrisonMember of Supervisory Board
Paulus StoffelsMember of Supervisory Board
David PyottMember of Supervisory Board
Herna VerhagenMember of Supervisory Board
Indra Krishnamurthy NooyiMember of Supervisory Board
Mary DohertyMember of Supervisory Board
Peter D. LöscherMember of Supervisory Board
Sanjay PoonenMember of Supervisory Board
Sock Koong ChuaMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer